Related Content
Gregg Stone, M.D., presents the results of the PROSPECT ABSORB Trial in a press conference at the 2020 ranscatheter ...
October 16, 2020 – Results from the XIENCE 90/28 clinical trials have shown that a shorter course of dual-antiplatelet ...
Nick West, M.D., chief medical officer for Abbott, explains the details from a survey of 1,400 patients, physicians and ...
Although not a new technology, optical coherence tomography (OCT) is the dark horse of imaging that could give ...
September 14, 2020 — New global research released by Abbott takes a deep dive into the barriers of cardiovascular ...
Nick West, M.D., chief medical officer for Abbott, explains the details from a survey of 1,400 patients, physicians and ...
August 4, 2020 — Abbott announced the first enrollments in the TactiFlex PAF investigational device exemption (IDE) ...
July 13, 2020 — Edwards Lifesciences Corp. and Abbott Vascular announced the two companies have reached an agreement to ...
July 13, 2020 - The U.S. Food and Drug Administration (FDA) has approved Abbott's next-generation Gallant implantable ...
June 26, 2020 — Abbott announced new data from the company's LightLab Initiative that showed optical coherence ...